ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in London, England

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Adenocarcinoma
Endometrial Cancer
Breast Cancer

Prostate Cancer trials near London, England, GBR:

TherApeutics in Early ProState Cancer (TAPS02)

trial investigating the use of short term androgen deprivation therapy in the form of apalutamide (Erleada) in men on active surveillance for prostate...

Enrolling
Prostate Cancer
Drug: Apalutamide Oral Tablet [Erleada]
Drug: Placebo

Phase 2

NHS Foundation Trust
NHS Foundation Trust

London, United Kingdom and 5 other locations

Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, pros...

Enrolling
Localized Prostate Cancer
Device: Aquablation Therapy
Procedure: Radical Prostatectomy
PROCEPT BioRobotics

London, United Kingdom and 38 other locations

androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone analogue (LHRHA) in men having radiation therapy for localised prostate...

Active, not recruiting
Prostate Cancer
Drug: Placebo oral tablet
Drug: Luteinizing Hormone-Releasing Hormone Analog

Phase 3

University of Sydney

London, United Kingdom and 92 other locations

This is a Phase 1/2, open-label, randomized, dose finding and dose expansion study to evaluate the safety, preliminary efficacy, and PK of gedatolisi...

Enrolling
Prostatic Disease
mCRPC (Metastatic Castration-resistant Prostate Cancer)
Drug: Gedatolisib
Drug: Darolutamide

Phase 1, Phase 2

Celcuity

Sutton, United Kingdom and 12 other locations

The purpose of this study is to investigate potential drug-drug interaction (DDI) between JNJ-56021927 and abiraterone acetate and between JNJ-560219...

Active, not recruiting
Metastatic Castration-Resistant Prostate Cancer
Prostatic Neoplasms
Drug: Prednisone
Drug: Abiraterone Acetate

Phase 1

Aragon Pharmaceuticals

Sutton, United Kingdom and 6 other locations

Effects of Saruparib (AZD5305) Alone, Darolutamide Alone, and in Combination Given Prior to Radical Prostatectomy in Men with Newly Diagnosed Prostate...

Enrolling
Prostate Cancer
Drug: Saruparib (AZD5305)
Drug: Darolutamide

Phase 1

AstraZeneca
AstraZeneca

Cambridge, United Kingdom and 18 other locations

The study will be conducted in 4 parts and will commence with dose escalation of AMX-500 as a monotherapy (Part 1), followed by monotherapy dose expa...

Enrolling
Hormone-refractory Prostate Cancer
Drug: AMX-500 (SAR446329)

Phase 1, Phase 2

Vir Biotechnology

London, United Kingdom and 7 other locations

the SpaceOAR Vue System in reducing late gastrointestinal (GI) toxicity in subjects undergoing Stereotactic Body Radiotherapy (SBRT) to treat prostate...

Active, not recruiting
Prostate Cancer
Device: SpaceOAR Vue System
Boston Scientific
Boston Scientific

London, United Kingdom and 29 other locations

with high-risk and very high-risk localised/locally advanced prostate cancer with a breast cancer gene mutation (BRCAm)....

Not yet enrolling
Prostate Cancer
Drug: Saruparib
Drug: Abiraterone + Prednisolone/Prednisone

Phase 3

AstraZeneca
AstraZeneca

London, United Kingdom and 145 other locations

ASpiRE will investigate the effect of the drug SX-682 in combination with Apalutamide in men suffering from metastatic castration-resistant prostate...

Enrolling
Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
Drug: Apalutamide
Drug: SX-682

Phase 1, Phase 2

Institute of Cancer Research, United Kingdom

Sutton, United Kingdom and 3 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems